Signposts: What to Look for and When to Seek Help

  • Anne M. Lipton
  • Cindy D. Marshall


If you are reading this book, you probably have some knowledge of dementia and its warning signs. However, much more awareness is needed, including in the medical community. Unfortunately, patients are very often not diagnosed with dementia or referred to dementia specialists until 2–3 years after the onset of their symptoms [1]. Not only laypeople, but many medical professionals, continue to hold a mistaken and outmoded viewpoint that nothing can be done for dementia. This nihilism is unwarranted and can even be harmful in delaying or preventing appropriate intervention or resulting in inappropriate or deleterious treatment. Earlier detection of dementia often allays anxieties about unnamed and undiagnosed problems and allows a chance to capitalize on planning, treatment, and research opportunities.


Obstructive Sleep Apnea Mild Cognitive Impairment Dementia With Lewy Body Progressive Supranuclear Palsy Vascular Risk Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jost BC, Grossberg GT. The natural history of Alzheimer’s disease: a brain bank study. J Am Geriatr Soc. 1995;43(11):1248–55.PubMedGoogle Scholar
  2. 2.
    Weiner MF, Lipton AM, editors. The American psychiatric publishing textbook of Alzheimer disease and other dementias. Washington, DC: American Psychiatric Publishing, Inc.; 2009.Google Scholar
  3. 3.
    Weiner MF, Lipton AM, editors. Clinical manual of Alzheimer disease and other dementias. Washington, DC: American Psychiatric Publishing, Inc.; 2012.Google Scholar
  4. 4.
    McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack Jr CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimers Dement. 2011;7(3):263–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Morris JC. Differential diagnosis of Alzheimer’s disease. Clin Geriatr Med. 1994;10(2): 257–76.PubMedGoogle Scholar
  6. 6.
    Albert M, DeKosky ST, Dickson D, Dubois B, Feldman H, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: report of the National Institute on Aging and the Alzheimer’sAssociation workgroup. Alzheimers Dement. 2011;7(3):270–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Petersen RC. Conversion. Neurology. 2006;67:S12–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Morris JC. Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria. Arch Neurol. 2006;63:15–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, Decarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77(5):461–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2005;20:1255–63.PubMedCrossRefGoogle Scholar
  12. 12.
    Aarsland D, Andersen K, Larsen JP, Lolk A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol. 2003;60:387–92.PubMedCrossRefGoogle Scholar
  13. 13.
    McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Knopman DS, Petersen RC, Edland SD, et al. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology. 2004;62:506–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology. 2002;58:1615–21.PubMedCrossRefGoogle Scholar
  16. 16.
    Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126: 2016–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546–54.PubMedCrossRefGoogle Scholar
  18. 18.
    McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Rascovsky K, Hodges JR, Kipps CM, Johnson JK, Seeley WW, Mendez MF, et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord. 2007;21:S14–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Mehta KM, Ott A, Kalmijn S, Slooter AJ, van Duijn CM, Hofman A, Breteler MM. Head trauma and risk of dementia and Alzheimer’s disease: the Rotterdam Study. Neurology. 1999;53(9):1959–62.PubMedCrossRefGoogle Scholar
  21. 21.
    Omalu B, Bailes J, Hamilton RL, Kamboh MI, Hammers J, Case M, Fitzsimmons R. Emerging histomorphologic phenotypes of chronic traumatic encephalopathy in American athletes. Neurosurgery. 2011;69(1):173–83.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  • Anne M. Lipton
    • 1
  • Cindy D. Marshall
    • 2
  1. 1.Diplomate in NeurologyAmerican Board of Psychiatry and NeurologyBuffalo GroveUSA
  2. 2.Memory Center, Baylor Neuroscience CenterBaylor University Medical CenterDallasUSA

Personalised recommendations